Login to Your Account



Valeant Drug Effective, but Safety Concerns Raised

By Donna Young


Tuesday, August 10, 2010
WASHINGTON – Investors were relieved Monday after FDA reviewers said Valeant Pharmaceuticals International Inc.'s experimental epilepsy drug Potiga (ezogabine/retigabine) was effective as an adjunctive treatment for partial onset seizures. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription